491 related articles for article (PubMed ID: 37476590)
1. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
[TBL] [Abstract][Full Text] [Related]
2. The Gut Microbiome and Pancreatic Cancer Development and Treatment.
Attebury H; Daley D
Cancer J; 2023 Mar-Apr 01; 29(2):49-56. PubMed ID: 36957973
[TBL] [Abstract][Full Text] [Related]
3. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
Liu L; Shah K
JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
5. Roles of microbiota in pancreatic cancer development and treatment.
Cruz MS; Tintelnot J; Gagliani N
Gut Microbes; 2024; 16(1):2320280. PubMed ID: 38411395
[TBL] [Abstract][Full Text] [Related]
6. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
[TBL] [Abstract][Full Text] [Related]
7. Advances in research on the relationship between the gut microbiome and cancer.
Song P; Wang QB; Liang B; Jiang SJ
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5104-5112. PubMed ID: 34486684
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
9. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
Gately S
Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome as a treatment in colorectal cancer.
Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma.
Pandya G; Kirtonia A; Singh A; Goel A; Mohan CD; Rangappa KS; Pandey AK; Kapoor S; Tandon S; Sethi G; Garg M
Semin Cancer Biol; 2022 Nov; 86(Pt 3):682-692. PubMed ID: 34051351
[TBL] [Abstract][Full Text] [Related]
13. Association of the gut microbiome with cancer immunotherapy.
Nomura M
Int J Clin Oncol; 2023 Mar; 28(3):347-353. PubMed ID: 35568746
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy.
Vitiello GA; Cohen DJ; Miller G
Trends Cancer; 2019 Nov; 5(11):670-676. PubMed ID: 31735286
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiome and melanoma: A review.
Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
[TBL] [Abstract][Full Text] [Related]
16. The microbiome and hepatobiliary-pancreatic cancers.
Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome in modulating immune checkpoint inhibitors.
Li X; Zhang S; Guo G; Han J; Yu J
EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment.
Zhou D; Li Y
Gut Microbes; 2023 Dec; 15(2):2276314. PubMed ID: 37943609
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.
Shui L; Yang X; Li J; Yi C; Sun Q; Zhu H
Front Immunol; 2019; 10():2989. PubMed ID: 32010123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
